(Pro)renin receptor triggers distinct angiotensin ii-independent extracellular matrix remodeling and deterioration of cardiac function

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Moilanen, Anne Mari ^a   Rysä, Jaana ^a   Serpi, Raisa ^a   Mustonen, Erja ^a   Szabò, Zoltán ^a   Aro, Jani ^a   Näpänkangas, Juha ^a   Tenhunen, Olli ^a   Sutinen, Meeri ^b   Salo, Tuula ^b,c   Ruskoaho, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CONNECTIVE TISSUE GROWTH FACTOR; HEAT SHOCK PROTEIN 27; LOSARTAN; MYOSIN HEAVY CHAIN BETA; PRORENIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOTIC MINIPUMP; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT; STROKE;

ADENOVIRIDAE; ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROSIS; GENE TRANSFER TECHNIQUES; HEART FUNCTION TESTS; HEART VENTRICLES; HSP27 HEAT-SHOCK PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LOSARTAN; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; UP-REGULATION; WNT SIGNALING PATHWAY;

ADENOVIRIDAE; ANIMALIA; RATTUS;

EID: 84864230215     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041404     Document Type: Article

References (45)

1. Jessup M, Brozena S, (2003) Heart failure. N Engl J Med 348: 2007-2018.
2. Bader M, (2010) Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 50: 439-465.
3. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, et al. (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417-1427.
4. Burcklé CA, Jan Danser AH, Müller DN, Garrelds IM, Gasc JM, et al. (2006) Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47: 552-556.
5. Kaneshiro Y, Ichihara A, Takemitsu T, Sakoda M, Suzuki F, et al. (2006) Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int 70: 641-646.
6. Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, et al. (2007) Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 18: 1789-1795.
7. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN, (2008) The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol 19: 743-748.
8. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, et al. (2009) The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 54: 261-269.
9. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, et al. (2010) Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327: 459-463.
10. Kinouchi K, Ichihara A, Sano M, Sun-Wada GH, Wada Y, et al. (2010) The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res 107: 30-34.
11. Tenhunen O, Soini Y, Ilves M, Rysä J, Tuukkanen J, et al. (2006) p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms. FASEB 20: 1907-1909.
12. Szatkowski ML, Westjall MV, Gomez CA, Wahr PA, Michele DE, et al. (2001) In vivo acceleration of heart relaxation performance by parvalbumin gene delivery. J Clin Invest 107: 191-198.
13. Tenhunen O, Rysä J, Ilves M, Ruskoaho H, Leskinen H, (2006) Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 MAPK in the heart. Circ Res 99: 485-493.
14. Rysä J, Tenhunen O, Serpi R, Soini Y, Nemer M, et al. (2010) GATA-4 is an angiogenic survival factor of the infarcted heart. Circ Heart Fail 3: 440-450.
15. Moilanen AM, Rysä J, Mustonen E, Serpi R, Aro J, et al. (2011) Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms. Circ Heart Fail 4: 483-495.
16. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, et al. (2006) Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47: 894-900.
17. Hirose T, Mori N, Totsune K, Morimoto R, Maejima T, et al. (2009) Gene expression of (pro)renin receptor is upregulated in hearts and kidneys of rats with congestive heart failure. Peptides 30: 2316-2322.
18. Mahmud H, Silljé HH, Cannon MV, van Gilst WH, de Boer RA, (2011) Regulation of the (pro)renin-renin receptor in cardiac remodeling. J Cell Mol Med doi:10.1111/j.1582-4934.2011.01377.x.
19. Serpi R, Tolonen AM, Tenhunen O, Pieviläinen O, Kubin AM, et al. (2009) Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction. Clin Transl Sci 2: 422-430.
20. Lakó-Futó Z, Szokodi I, Sármán B, Földes G, Tokola H, et al. (2003) Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart. Circulation 108: 2414-2422.
21. Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H, (1997) Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression. Circ Res 81: 694-702.
22. Hautala N, Tokola H, Luodonpää M, Puhakka J, Romppanen H, et al. (2001) Pressure overload increases GATA4 binding activity via endothelin-1. Circulation 103: 730-735.
23. Tenhunen O, Sarman B, Kerkelä R, Szokodi I, Papp L, et al. (2004) Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heart. J Biol Chem 279: 24852-24860.
24. Rysä J, Leskinen H, Ilves M, Ruskoaho H, (2005) Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 45: 927-933.
25. Nyberg P, Heikkilä P, Sorsa T, Luostarinen J, Heljasvaara R, et al. (2003) Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2,-9, and-13. J Biol Chem 278: 22404-22411.
26. Soini Y, Virkajärvi N, Lehto V-P, Pääkkö P, (1996) Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 73: 1025-1030.
27. Connelly KA, Advani A, Kim S, Advani SL, Zhang M, et al. (2011) The cardiac (pro)renin receptor is primarily expressed in myocyte transverse tubules and is increased in experimental diabetic cardiomyopathy. J Hypertens 29: 1175-1184.
28. French BA, Mazur W, Geske RS, Bolli R, (1994) Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 90: 2414-2424.
29. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T, (1993) Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 73: 1202-1207.
30. Ruskoaho H, (1992) Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev 44: 479-602.
31. Frey N, Olson EN, (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79.
32. Lompré AM, Hajjar RJ, Harding SE, Kranias EG, Lohse MJ, et al. (2010) Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 121: 822-830.
33. Zhao T, Zhao W, Chen Y, Ahokas RA, Sun Y, (2010) Vascular endothelial growth factor (VEGF)-A: Role on cardiac angiogenesis following myocardial infarction. Microvasc Res 80: 188-194.
34. Detillieux KA, Sheikh F, Kardami E, Cattini PA, (2003) Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57: 8-19.
35. Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, et al. (2006) A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99: 1355-1366.
36. Nguyen G, (2011) Renin, pro(renin) and receptor: an update. Clin Sci 120: 169-178.
37. van Esch JH, van Veghel R, Garrelds IM, Leijten F, Bouhuizen AM, et al. (2011) Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats. Hypertension 57: 852-858.
38. Brown RD, Ambler SK, Mitchell MD, Long CS, (2005) The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45: 657-87.
39. Dorn GW, Force T, (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115: 527-537.
40. Heineke J, Molkentin JD, (2006) Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol 7: 589-600.
41. Walsh K, Shiojima I, (2007) Cardiac growth and angiogenesis coordinated by intertissue interactions. J Clin Invest 117: 3176-3179.
42. Burridge K, Wennerberg K, (2004) Rho and Rac take center stage. Cell 116: 167-179.
43. Whelan RS, Kaplinskiy V, Kitsis RN, (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72: 19-44.
44. Weig HJ, Laugwitz KL, Moretti A, Kronsbein K, Städele C, et al. (2000) Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Circulation 101: 1578-1585.
45. Batenburg WW, Lu X, Leijten F, Maschke U, Müller DN, et al. (2011) Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur? Hypertension 58: 1111-1119.